Sigyn Therapeutics, Inc.
SIGY
$4.10
-$0.0099-0.24%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 164.80K | 53.60K | 32.80K | 11.70K | 64.60K |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | 50.00K | 50.00K | 50.00K | 50.00K | 50.00K |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 54.30K | 42.70K | 51.60K | 56.40K | 54.30K |
Total Current Assets | 269.10K | 146.40K | 134.40K | 118.10K | 168.90K |
|
|||||
Total Current Assets | 269.10K | 146.40K | 134.40K | 118.10K | 168.90K |
Net Property, Plant & Equipment | 137.60K | 153.10K | 168.20K | 183.00K | 197.60K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | 0.00 | 0.00 |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 20.70K | 20.70K | 20.70K | 20.70K | 20.70K |
Total Assets | 427.40K | 320.20K | 323.30K | 321.80K | 387.20K |
|
|||||
Total Accounts Payable | 611.60K | 488.40K | 529.50K | 461.60K | 361.60K |
Total Accrued Expenses | 1.76M | 1.49M | 1.08M | 791.80K | 405.20K |
Short-term Debt | 1.83M | 1.85M | 2.56M | 2.29M | 2.99M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 67.70K | 65.40K | 63.20K | 61.10K | 59.10K |
Total Finance Division Other Current Liabilities | 0.00 | 2.20K | 2.60K | 3.20K | 1.80K |
Total Other Current Liabilities | 0.00 | 2.20K | 2.60K | 3.20K | 1.80K |
Total Current Liabilities | 4.28M | 3.90M | 4.23M | 3.61M | 3.82M |
|
|||||
Total Current Liabilities | 4.28M | 3.90M | 4.23M | 3.61M | 3.82M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 1.83M | 1.85M | 2.56M | 2.29M | 2.99M |
Capital Leases | 74.70K | 92.70K | 109.80K | 126.30K | 142.40K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 4.35M | 3.99M | 4.34M | 3.73M | 3.96M |
|
|||||
Common Stock & APIC | 10.24M | 9.29M | 8.08M | 7.93M | 6.59M |
Retained Earnings | -14.16M | -12.96M | -12.10M | -11.34M | -10.17M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -3.92M | -3.67M | -4.02M | -3.41M | -3.58M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -3.92M | -3.67M | -4.02M | -3.41M | -3.58M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -3.92M | -3.67M | -4.02M | -3.41M | -3.58M |
|